Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Prioderm 0.5% lotion
1310040M0BCAAAC
|
Prioderm | Malathion | Skin | No data available |
|
Prioderm 1% cream shampoo
1310040M0BCABAB
|
Prioderm | Malathion | Skin | No data available |
|
Pro-Juven 1.5% cream
131500000BBMTA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Pro-Juven 3% cream
131500000BBMSA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Proflavine 0.1% cream
1310050T0AAAAAA
|
Proflavine (Topical) | Proflavine hemisulphate | Skin | No data available |
|
Proflavine 0.1% solution
1311060R0AAAAAA
|
Proflavine (Topical Disinfectant) | Proflavine | Skin | No data available |
|
Propaderm 0.025% cream
1304000C0BBAAAA
|
Propaderm | Beclometasone dipropionate | Skin | No data available |
|
Propaderm 0.025% ointment
1304000C0BBAEBA
|
Propaderm | Beclometasone dipropionate | Skin | No data available |
|
Propecia 1mg tablets
1309000W0BBAAAA
|
Propecia | Finasteride | Skin | No data available |
|
Propylene glycol 20% / Lactic acid 3% in Gen Unguentum M crm
130201000AADNDN
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Propylene glycol 20% / Lactic acid 5% in Gen Unguentum M crm
130201000AADPDP
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Propylene glycol 20% in Aqueous cream
130201000AACMCM
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Propylene glycol 20% in Clobetasol 0.05% cream
130400000AABKBK
|
Generic compound preparation BNF 1304000 | Other topical corticosteroid preparations | Skin | No data available |
|
Propylene glycol 25% in Aqueous cream
130201000AADIDI
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Propylene glycol 30% in Generic Unguentum M cream
130201000AADKDK
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Propylene glycol 40% in Generic Unguentum M cream
130201000AADCDC
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Propylene glycol 50% in Aqueous cream
130201000AADFDF
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Propylene glycol 50% in Clobetasol 0.05% cream
130400000AABHBH
|
Generic compound preparation BNF 1304000 | Other topical corticosteroid preparations | Skin | No data available |
|
Propylene glycol 50% in Clobetasol 0.05% ointment
1304000G0AACWCW
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Propylene glycol 60% in Aqueous cream
130201000AACVCV
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Psorin ointment
1305020F0BDAAAU
|
Psorin (Ointment) | Dithranol | Skin | No data available |
|
Psorin scalp gel
1309000V0BBAAAA
|
Psorin (Scalp) | Dithranol | Skin | No data available |
|
Pure Health Liquid Paraffin/White Soft Paraffin
130201000BBILA6
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Pyzchiva 45mg/0.5ml inj pre-filled syringes
1305030D0BCACAB
|
Pyzchiva | Ustekinumab | Skin | No data available |
|
Pyzchiva 90mg/1ml solution for injection pre-filled syringes
1305030D0BCABAC
|
Pyzchiva | Ustekinumab | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.